Tracking the results of drug safety and efficacy
Search results for: adalimumab
California Rheumatologists Explore Managed Care, Treatment Options
Advances in SLE, osteoporosis, and RA highlighted at California Rheumatology Alliance meeting.
Where Will Kinase Inhibitors Fit into the RA Treatment Mix?
Presenters at “Looking Ahead to Kinase Inhibition in Rheumatoid Arthritis,” a session here at the 2011 ACR/ARHP Annual Scientific Meeting, delved into some of the big questions that rheumatology faces with kinase inhibitor use.
Information on New Drug Approvals and Medication Safety
Rheumatology-related drug safety, approvals, and what’s in the pipeline.
The Science of MDHAQ/RAPID3 Scores
Do patient self-reports provide valid data for evidence-based care in rheumatology practice?
Drug Updates
Information on new approvals and medication safety
Drug Updates
Information on new approvals and medication safety
Drug Updates
Information on New Approvals and Medication Safety
Drug Updates
Information on New Approvals and Medication Safety
New Guidance for Rheumatologists who Treat JIA
Evidence and consensus-based recommendations reflects current knowledge about initiation of therapy